The First WHO integrated meeting on development and clinical trials of Influenza vaccines that induce broadly protective and long-lasting immune responses
24–26 January 2013, Hong Kong Baptist University, Hong Kong SAR, China
Day two selected presentations
25 January 2013
-
Current status of development and evaluation of Vero cell-derived vaccines
pdf, 1.01Mb
Otfried Kistner, Baxter BioScience, Austria -
Recombinant protein vaccines produced in insect cells
pdf, 1.53Mb
Manon Cox, Protein Sciences Corporation, USA -
Recombinant NP and NP-M2e expressed in Escherichia coli elicited robust immunity and heterologous protection against influenza A virus in mice
pdf, 1.25Mb
Li Ruan, CDC, China -
Universal influenza vaccine
pdf, 871kb
Tanya Gottlieb, Biond Vax Pharmaceuticals Ltd, Israel -
Update on production of plant-made influenza virus-like particle (VLP) vaccines
pdf, 1.88Mb
Nathalie Landry, Medicago R&D Inc., Canada -
Virosomal H5N1 vaccine adjuvanted with matrix M induces antibody and T cell responses in clinical trials
pdf, 1.47Mb
Rebecca Cox, University of Bergen, Norway -
Cationic liposome-DNA complexes (CLDC) adjuvant enhances the immunogenicity and cross-protective efficacy of influenza A H5N1 vaccine
pdf, 956kb
Xia-hua Lu, CDC, USA -
Enhanced immune response induced by vaccine based on branched M2e polypeptides linked to tuftsin
pdf, 890kb
Xiaoyu Liu, CDC, China -
Review on intradermal application of Influenza vaccines
pdf, 2.70Mb
Filippo Ansaldi, University of Genoa and Hygiene Unit, Italy -
Development and evaluation of influenza vaccines based on adenovirus and MVA as vectors
pdf, 802kb
Sarah Gilbert, The Jenner Institute, UK -
Role of nasal secretory IgA in children vaccinated with live attenuated influenza vaccine
pdf, 403kb
Christopher Ambrose, MedImmune, USA -
Intranasal vaccination with an inactivated whole virion vaccine in humans
pdf, 1.16Mb
Akira Ainai, National Institute of Infectious Diseases, Japan -
Review on vaccine safety in pregnant women
pdf, 1.33Mb
Janet Englund, Hong Kong Baptist University, Hong Kong -
Narcolepsy and influenza vaccination
pdf, 1.12Mb
Hanna Nohynek, National Institute for Health and Welfare, Finland -
Results from recent vaccine effectiveness studies: effect of prior year vaccination
pdf, 1.13Mb
Arnold Monto, The University of Michigan School of Public Health, Ann Arbor, USA -
Prediction of vaccination safety and pharmacovigilance
pdf, 393kb
Katherine Donegan, Medicines and Healthcare products Regulatory Agency, UK -
Requirements for quality control and registration of influenza vaccines developed using novel biotechnological approaches
pdf, 2.80Mb
Ralf Wagner, Paul-Ehrlich-Institut, Germany